Issued2025-08-13

Regulation of Software, Including AI – SaMD Rules and Guidance

GuidanceInternational

Summary

Detailed guidance on how the the Therapeutic Goods Administration regulates software-based medical devices, including SaMD definitions, classification, evidence, and obligations across the lifecycle. Recently updated to reflect AI considerations.

Healthcare Implications

Helps developers and providers determine when AI features trigger device regulation and what documentation is required. Supports procurement due diligence and clinical governance for AI-enabled software.

Impact Level

Medium

Keywords

Transparency & Governance; Clinical Quality & Efficacy